RAP 0.00% 20.5¢ resapp health limited

Ann: Medgate commences European ResAppDx trial, page-4

  1. Dhm
    2,363 Posts.
    lightbulb Created with Sketch. 3427
    I like this:
    Dr Andy Fischer, CEO Medgate said: "We are absolutely convinced that the use of new technologies like ResAppDx will enable an advancement of our Digital Health platform. This will benefit our patients by enabling them to be treated conclusively by phone or video in even more cases."

    I know this is only white noise and fluff, but it still gives me confidence in ResApp's future.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.